je.st
news
Company will create new swine vaccines based on advanced mucosal technology
2015-07-07 21:29:38| National Hog Farmer
Aptimmune Biologics, a mucosal vaccine company developing novel swine vaccines for PRRSV and influenza virus, has received $2.75 million of funding from Arsenal Capital Management, Fox Ventures LLC, and a group of Midwest angel investors. “PRRSV and influenza virus are a growing threat to swine health worldwide. Their combined annual economic impact on the U.S. swine industry alone is over $1.4 billion. Our new vaccine portfolio will change the management of these diseases, significantly improve swine health and producer productivity,” said Dr. read more
Tags: advanced
company
based
create
Category:Agriculture and Forestry